Meningococcal Conjugate Vaccine in Adolescents and Children

No abstract is available for this paper.

• Publication year

  2005

• Venue

  La Clinica pediatrica

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000992280504400603PMID 16015394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children

  2005cited by this paper
• Protective Activity of Group C Anticapsular Antibodies Elicited in Two-Year-Olds by an Investigational Quadrivalent Neisseria meningitidis-Diphtheria Toxoid Conjugate Vaccine

  2004cited by this paper
• Augmentation of the Immune Response to a Quadrivalent Meningococcal (A,C,Y,W-135) Diphtheria Conjugate Vaccine (MCV-4) by Co-administration with Tetanus-diphtheria Vaccine (Td) in Healthy Adolescents

  2004cited by this paper
• Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

  2004cited by this paper
• Summary of notifiable diseases--United States, 2001.

  2003cited by this paper
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

  2003cited by this paper
• Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

  2002cited by this paper
• Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children

  2002cited by this paper
• Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants

  2002cited by this paper
• Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

  2002cited by this paper
• Impact of meningococcal C conjugate vaccine in the UK.

  2002cited by this paper
• Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

  2001cited by this paper
• Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

  2001cited by this paper
• Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

  2001cited by this paper
• Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

  2000cited by this paper
• Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

  1999cited by this paper
• Risk of meningococcal infection in college students.

  1999cited by this paper
• Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.

  1999cited by this paper
• The changing epidemiology of meningococcal disease in the United States, 1992-1996.

  1999cited by this paper
• Efficacy of meningococcal vaccine and barriers to vaccination.

  1998cited by this paper
• Bacterial meningitis in the United States in 1995. Active Surveillance Team.

  1997cited by this paper
• Bacterial Meningitis in the United States in 1995

  1997cited by this paper
• Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

  1997cited by this paper
• Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.

  1996cited by this paper
• Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.

  1996cited by this paper
• Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.

  1993cited by this paper
• Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study

  1985cited by this paper

• High diversity of Escherichia coli causing invasive disease in neonates in Malawi poses challenges for O-antigen based vaccine approach

  2024cites this paper
• Analytical Challenges in Novel Pentavalent Meningococcal Conjugate Vaccine (A, C, Y, W, X)

  2024cites this paper
• The Ongoing Journey of a Shigella Bioconjugate Vaccine

  2022cites this paper
• The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli.

  2018cites this paper
• Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial.

  2017cites this paper
• Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

  2012cites this paper
• Characterization of carbohydrate based vaccines

  2012cites this paper
• Análise e determinação de custos específicos e consequências econômico-sociais na incorporação da vacina contra meningite e doença meningocócica C conjugada na rotina do Programa Nacional de Imunização/PNI

  2011cites this paper
• Bacterial outer membrane vesicles in disease and preventive medicine

  2011cites this paper
• Immunisation of adolescents in the UK

  2010cites this paper
• Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign

  2010cites this paper
• Vi polysaccharide–protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?

  2007cites this paper
• Epidemiology of bacterial meningitis in Lombardy Region in the period 2000-2006.

  2007cites this paper
• Bibliography. Current world literature. Hematology and oncology.

  2006cites this paper
• A review of vaccine research and development: meningococcal disease.

  2006cites this paper